Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Lyon

Showing results (521-530 of 539) with videos related to

Pageof 54
Sort By:
European Heart Journal|October 9, 2018
Treatments targeting inotropyChristoph Maack, Thomas Eschenhagen, Nazha Hamdani, et al.
European Journal of Heart Failure|July 4, 2020
Sodium-glucose co-transporter 2 inhibitors in heart failure: beyond glycaemic control. A position paper of the Heart Failure Association of the European Society of CardiologyPetar M Seferović, Gabriele Fragasso, Mark Petrie, et al.
European Journal of Heart Failure|October 2, 2020
Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of CardiologyRadek Pudil, Christian Mueller, Jelena Čelutkienė, et al.
Journal for Immunotherapy of Cancer|March 3, 2021
Electrocardiographic features of immune checkpoint inhibitor associated myocarditisDaniel A Zlotoff, Malek Z O Hassan, Amna Zafar, et al.
Journal for Immunotherapy of Cancer|February 24, 2019
Influenza vaccination and myocarditis among patients receiving immune checkpoint inhibitorsMagid Awadalla, Doll Lauren Alexandra Golden, Syed S Mahmood, et al.
JACC. Cardiooncology|January 11, 2024
Priorities in Cardio-Oncology Basic and Translational Science: GCOS 2023 Symposium Proceedings: <i>JACC: CardioOncology</i> State-of-the-Art ReviewFadi N Salloum, Carlo G Tocchetti, Pietro Ameri, et al.
European Journal of Heart Failure|March 28, 2017
New medicinal products for chronic heart failure: advances in clinical trial design and efficacy assessmentMartin R Cowie, Gerasimos S Filippatos, Maria de Los Angeles Alonso Garcia, et al.
European Journal of Heart Failure|October 23, 2020
Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)Rudolf A de Boer, Jean-Sébastien Hulot, Carlo Gabriele Tocchetti, et al.
Nature|January 17, 2017
Evolutionary genomics of the cold-adapted diatom Fragilariopsis cylindrusThomas Mock, Robert P Otillar, Jan Strauss, et al.
European Heart Journal|April 9, 2019
The continuous heart failure spectrum: moving beyond an ejection fraction classificationFilippos Triposkiadis, Javed Butler, Francois M Abboud, et al.
Pageof 54

Showing results (521-530 of 539) with videos related to

Sort By:
Pageof 54
European Heart Journal|October 9, 2018
Treatments targeting inotropyChristoph Maack, Thomas Eschenhagen, Nazha Hamdani, et al.
European Journal of Heart Failure|July 4, 2020
Sodium-glucose co-transporter 2 inhibitors in heart failure: beyond glycaemic control. A position paper of the Heart Failure Association of the European Society of CardiologyPetar M Seferović, Gabriele Fragasso, Mark Petrie, et al.
European Journal of Heart Failure|October 2, 2020
Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of CardiologyRadek Pudil, Christian Mueller, Jelena Čelutkienė, et al.
Journal for Immunotherapy of Cancer|March 3, 2021
Electrocardiographic features of immune checkpoint inhibitor associated myocarditisDaniel A Zlotoff, Malek Z O Hassan, Amna Zafar, et al.
Journal for Immunotherapy of Cancer|February 24, 2019
Influenza vaccination and myocarditis among patients receiving immune checkpoint inhibitorsMagid Awadalla, Doll Lauren Alexandra Golden, Syed S Mahmood, et al.
JACC. Cardiooncology|January 11, 2024
Priorities in Cardio-Oncology Basic and Translational Science: GCOS 2023 Symposium Proceedings: <i>JACC: CardioOncology</i> State-of-the-Art ReviewFadi N Salloum, Carlo G Tocchetti, Pietro Ameri, et al.
European Journal of Heart Failure|March 28, 2017
New medicinal products for chronic heart failure: advances in clinical trial design and efficacy assessmentMartin R Cowie, Gerasimos S Filippatos, Maria de Los Angeles Alonso Garcia, et al.
European Journal of Heart Failure|October 23, 2020
Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)Rudolf A de Boer, Jean-Sébastien Hulot, Carlo Gabriele Tocchetti, et al.
Nature|January 17, 2017
Evolutionary genomics of the cold-adapted diatom Fragilariopsis cylindrusThomas Mock, Robert P Otillar, Jan Strauss, et al.
European Heart Journal|April 9, 2019
The continuous heart failure spectrum: moving beyond an ejection fraction classificationFilippos Triposkiadis, Javed Butler, Francois M Abboud, et al.
Pageof 54